Apoptosis is an evolutionarily conserved and tightly regulated cell death pathway. Physiological cell death is important for maintaining homeostasis and optimal biological conditions by continuous elimination of undesired or superfluous cells. The BH3-only pro-apoptotic members are strong inducers of apoptosis. The pro-apoptotic BH3-only protein Noxa activates multiple death pathways by inhibiting the anti-apoptotic Bcl-2 family protein, Mcl-1, and other protein members leading to Bax and Bak activation and MOMP. On the other hand, Puma is induced by p53-dependent and p53-independent apoptotic stimuli in several cancer cell lines. Moreover, this protein is involved in several physiological and pathological processes, such as immunity, cancer, and neurodegenerative diseases. Future heat shock research could disclose the effect of hyperthermia on both Noxa and BH3-only proteins. This suggests post-transcriptional mechanisms controlling the translation of both Puma and Noxa mRNA in heat-shocked cells. This study was also the chance to recapitulate the different reactional mechanisms investigated for caspases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875537 | PMC |
| http://dx.doi.org/10.3390/life12020256 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer.
Cell Death Dis
December 2024
Department of Molecular Biology of Cancer, Medical University of Lodz, 6/8 Mazowiecka Street, 92-215, Lodz, Poland.
Apoptosis-regulating proteins from the B-cell lymphoma-2 (BCL-2) family are of continued interest as they represent promising targets for anti-cancer therapies. Myeloid cell leukemia-1 (MCL-1), which usually refers to the long isoform (MCL-1L) is frequently overexpressed in various types of cancer. However, MCL1 pre-mRNA can also undergo alternative splicing through exon skipping to yield the short isoform, MCL-1S.
View Article and Find Full Text PDFThe replicative helicase CMG is required for the divergence of cell fates during asymmetric cell division in vivo.
Nat Commun
October 2024
Research Department Cell and Developmental Biology, Division of Biosciences, University College London, London, UK.
Article Synopsis
- The CMG helicase complex is essential for controlling gene expression during asymmetric cell divisions in C. elegans.
- The specific component PSF-2 GINS2 is necessary for activating the pro-apoptotic gene egl-1, which is crucial for programmed cell death.
- The study highlights CMG's role in influencing cell fates and suggests it affects gene expression beyond just egl-1 regulation.
Apoptosis signaling is activated as a transient pulse in neurons.
Cell Death Differ
October 2024
Neuroscience Center; University of North Carolina, Chapel Hill, NC, USA.
Apoptosis is a fundamental process of all mammalian cells but exactly how it is regulated in different primary cells remains less explored. In most contexts, apoptosis is engaged to eliminate cells. However, postmitotic cells such as neurons must efficiently balance the need for developmental apoptosis versus the physiological needs for their long-term survival.
View Article and Find Full Text PDFInhibition of BAK-mediated apoptosis by the BH3-only protein BNIP5.
Cell Death Differ
October 2024
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
BCL-2 family proteins regulate apoptosis by initiating mitochondrial outer membrane permeabilization (MOMP). Activation of the MOMP effectors BAX and BAK is controlled by the interplay of anti-apoptotic BCL-2 proteins (e.g.
View Article and Find Full Text PDFProapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors.
Mol Cancer
October 2024
Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, 200 First Street, S.W., Rochester, MN, 55905, USA.
Article Synopsis
- Researchers are studying drugs called replication checkpoint modulators (RCMs) that could help treat tough ovarian cancer, but they are not very effective by themselves.
- When these drugs are used on cancer cells, they change certain proteins inside the cells, which makes them struggle to divide and can lead to cell death.
- The study shows that these drugs can help shrink tumors even in stubborn cases, meaning they could be useful for patients with this type of cancer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!